Patients with Alzheimer's disease major neurocognitive disorder benefit from medications that work by

Question

Quizplus · Accepted Answer

Patients with Alzheimer's disease suffer from a decrease in the levels of acetylcholine, a neurotransmitter responsible for learning and memory. Medications that prevent the breakdown of acetylcholine, such as cholinesterase inhibitors, have been shown to improve cognitive functioning in these patients. Enhancing levels of dopamine or preventing the reuptake of serotonin are not effective treatments for Alzheimer's disease. The exact processes underlying the disease are not yet fully understood, but medications that target acetylcholine have been shown to be effective.

Patients with Alzheimer's Disease Major Neurocognitive Disorder Benefit from Medications